Progyny (PGNY) Reiterated at Market Outperform by Citizens as Addressable Market Grows

September 2, 2026 4:19 AM

Citizens analyst Constantine Davides reiterated a Market Outperform rating and $31.00 price target on Progyny (NASDAQ: PGNY).The analyst commented, "The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found